Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Orthopedic Devices Market Size & Growth Forecast 2026–2035, By Segments (End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 13997| Published Date: Jun-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Orthopedic Devices Market size was worth USD 64.85 Billion in 2025 and is expected to grow at a 4.4% CAGR between 2026 and 2035, crossing USD 99.75 Billion by 2035. The industry revenue for 2026 is assessed at USD 67.3 billion.

Base Year Value (2025)
USD 64.85 Billion
CAGR (2026-2035)
4.4%
Forecast Year Value (2035)
USD 99.75 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Orthopedic Devices Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 47.70% market share in 2025, driven by mature orthopedic care, strong adoption of advanced implants, high procedure volumes, and broad access to specialized treatment.
  • Asia Pacific is expected to expand at a 5.02% CAGR as healthcare access improves, hospital infrastructure grows, and more patients receive orthopedic diagnosis, surgery, and modern device-based treatment.

Segment Momentum

  • Hospitals represented 62.57% of the market in 2025, driven by their advanced surgical infrastructure, specialized orthopedic teams, and ability to manage complex procedures, trauma care, and rehabilitation services.
  • Orthobiologics is growing rapidly as surgeons increasingly use regenerative solutions to enhance bone healing and tissue repair alongside conventional orthopedic procedures and implant-based treatments.

Market Expansion Drivers

  • Rising global aging population increasing degenerative bone disorder prevalence.
  • Growing adoption of robotic-assisted orthopedic surgery improving precision and recovery outcomes.
  • Expansion of ambulatory surgery centers shifting orthopedic procedures toward outpatient settings.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Top companies in the orthopedic devices market include Medtronic plc (Ireland), Stryker Corporation (United States), Zimmer Biomet Holdings, Inc. (United States), DePuy Synthes, Inc. (United States), Smith & Nephew plc (United Kingdom), B. Braun Melsungen AG (Germany), CONMED Corporation (United States), Globus Medical, Inc. (United States), Enovis Corporation (United States), Arthrex, Inc. (United States).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising global aging population increasing degenerative bone disorder prevalence

As populations age, the orthopedic devices market is seeing stronger procedure volumes tied to osteoarthritis, osteoporosis, spinal degeneration, and joint deterioration that progressively reduce mobility and quality of life. This shifts demand toward implants, fixation devices, joint reconstruction systems, and related surgical solutions because older patients are more likely to require intervention after conservative treatment loses effectiveness. The practical effect is not only higher case volumes but a broader replacement cycle for hips, knees, and spine-related devices, aiding market expansion as healthcare providers allocate more resources to managing chronic musculoskeletal decline in elderly patient populations.

Growing adoption of robotic-assisted orthopedic surgery improving precision and recovery outcomes

The growing use of robotic platforms is influencing market adoption in the orthopedic devices market by changing how surgeons select implants, plan procedures, and position components during joint reconstruction. Greater precision in alignment and bone preparation supports the use of advanced implant systems designed to integrate with navigation and robotic workflows, while hospitals often use these capabilities to differentiate orthopedic service lines and attract higher procedure volumes. As confidence in improved recovery pathways and surgical consistency increases, capital investment in robotics also strengthens demand for compatible consumables, software-enabled instrumentation, and premium orthopedic device portfolios.

Expansion of ambulatory surgery centers shifting orthopedic procedures toward outpatient settings

The expansion of ambulatory surgery centers is reshaping purchasing and product preferences in the orthopedic devices market as more orthopedic procedures move into cost-sensitive outpatient environments. Device manufacturers are under pressure to provide implant systems and surgical instruments that reduce operating time, streamline sterilization and setup, and fit standardized high-throughput procedural models. This shift is increasing market adoption for minimally invasive and efficiency-oriented orthopedic solutions, while procurement decisions are becoming more closely tied to total procedural economics, recovery timelines, and the ability to discharge patients safely on the same day.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising global aging population increasing degenerative bone disorder prevalence 2.00% Moderate North America, Europe High Near Term
Growing adoption of robotic-assisted orthopedic surgery improving precision and recovery outcomes 1.80% High North America, Asia Pacific Medium Mid Term
Expansion of ambulatory surgery centers shifting orthopedic procedures toward outpatient settings 1.50% Moderate North America, Europe Medium Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
47.70% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 47.70% share of the orthopedic devices market in 2025, supported by a mature procedure environment, strong adoption of advanced implants and surgical technologies, and broad access to specialized orthopedic care. The region’s leadership is reinforced by high volumes of joint replacement, trauma, and spine procedures performed through well-established hospital networks and ambulatory settings, where providers are more equipped to integrate premium devices, navigation tools, and minimally invasive techniques into routine practice. A favorable reimbursement structure in key segments also helps sustain steady device utilization and replacement demand across both elective and medically necessary interventions.

Asia Pacific is projected to expand at a 5.02% CAGR over the forecast period, with growth in the orthopedic devices market being propelled by rising procedure adoption, improving healthcare access, and ongoing expansion of hospital and surgical infrastructure. Demand is accelerating as more patients gain access to orthopedic diagnosis and treatment, while providers across developing and developed markets in the region continue to increase capacity for trauma care, joint reconstruction, and other musculoskeletal interventions. The pace of growth is further supported by a widening treatment base and stronger penetration of modern orthopedic devices into healthcare systems that are still scaling procedural volume.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Precision Implant Development

Germany's orthopedic devices market benefits from strong demand for high-performance implants and technologically advanced fixation systems. Manufacturers are focusing on durable materials and precision-engineered devices that support complex orthopedic interventions.

France 🇫🇷

Personalized Treatment Pathways

France is increasingly incorporating orthopedic devices tailored to patient-specific surgical requirements and rehabilitation needs. Demand is growing for implants and fixation systems that support precision procedures and efficient postoperative care.

Italy 🇮🇹

Reconstructive Procedure Demand

Italy's orthopedic devices market is supported by sustained demand for reconstructive surgeries and trauma management solutions. Healthcare providers are focusing on implants and fixation devices that enhance durability and support functional recovery in aging populations.

Japan 🇯🇵

Aging Mobility Solutions

Japan is prioritizing orthopedic devices that address rising rates of degenerative bone and joint conditions among older adults. Demand remains concentrated in joint reconstruction and implants designed to improve mobility and long-term patient function.

South Korea 🇰🇷

Sports Medicine Expansion

South Korea's orthopedic devices market is seeing increased activity in sports injury treatment and minimally invasive orthopedic procedures. Hospitals are adopting advanced implants and surgical technologies that enable faster rehabilitation and improved clinical outcomes.

United States 🇺🇸

Innovation Driven Procedures

The U.S. orthopedic devices market is shaped by demand for advanced implants, robotic-assisted surgery, and technologies that improve procedural outcomes. Healthcare providers are investing in solutions that support minimally invasive techniques and accommodate increasing joint replacement volumes.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Orthopedic Devices Market Share (%), End-use, 2025

Hospitals
Outpatient Facilities

Go beyond the chart, access full insights & data tables

Request Free Sample Report
End-use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)

Hospitals held a 62.57% share of the orthopedic devices market in 2025, reflecting their central role in handling complex orthopedic procedures, trauma care, and high-volume joint reconstruction cases. This leadership is reinforced by their access to advanced surgical infrastructure, specialized orthopedic teams, and integrated perioperative services that support the use of a broad range of orthopedic devices. The same operating environment is also sustaining growth momentum, as hospitals remain the primary setting for procedures that require precision imaging, inpatient monitoring, and coordinated rehabilitation pathways, making them the most practical destination for rising demand across the orthopedic devices market.

Product Segment Analysis: Joint Replacement/Orthopedic Implants (Largest Segment) vs Orthobiologics (Fastest-Growing Segment)

Within the orthopedic devices market, Joint Replacement/Orthopedic Implants accounted for a 44.2% share in 2025, backed by their established use in treating degenerative joint conditions, severe fractures, and mobility-limiting orthopedic disorders. Their leadership continues to rest on routine procedural adoption in clinical practice, especially where structural repair or full joint restoration is required and implant-based intervention remains the standard treatment pathway.

Orthobiologics is emerging as the fastest-growing product segment in the orthopedic devices market because clinical preference is increasingly moving toward treatments that support bone healing and tissue regeneration alongside conventional orthopedic intervention. Its momentum is being influenced by practical use in cases where surgeons seek to improve healing outcomes or complement implant procedures, giving Orthobiologics a stronger growth profile than more mature product categories where adoption is already well established.

Segment Sub-Segment Largest Segment Fastest Growing
End-use Hospitals, Outpatient Facilities Hospitals Hospitals
Product Joint Replacement/Orthopedic Implants, Trauma, Sports Medicine, Orthobiologics, Others Joint Replacement/Orthopedic Implants Orthobiologics
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the orthopedic devices market:

1. Medtronic plc (Ireland)

2. Stryker Corporation (United States)

3. Zimmer Biomet Holdings Inc. (United States)

4. DePuy Synthes Inc. (United States)

5. Smith & Nephew plc (United Kingdom)

6. B. Braun Melsungen AG (Germany)

7. CONMED Corporation (United States)

8. Globus Medical Inc. (United States)

9. Enovis Corporation (United States)

10. Arthrex Inc. (United States)

The orthopedic devices market is evolving with growing adoption of robotic-assisted and precision-guided surgical tools. Enhanced implant designs are improving mobility restoration and long-term outcomes. Collaborative clinical ecosystems are supporting faster innovation cycles. The orthopedic devices market continues to advance toward highly personalized musculoskeletal treatment solutions.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Zimmer Biomet Mar-26 Following the successful acquisition of Paragon 28, Zimmer Biomet has launched two new orthopedic devices to bolster its lower-extremity portfolio. This expansion reflects the integration of recently acquired assets and a strategic focus on scaling its presence in the high-growth hip, knee, and foot and ankle segments to meet robust procedural demand.
Zydus Mar-26 Zydus Lifesciences has moved to acquire an 85.6% majority stake in French orthopedic device manufacturer Amplitude Surgical for approximately €257 million. This acquisition is a core component of Zydus’ international growth strategy, providing the company with advanced lower-limb orthopedic technologies and a strengthened industrial footprint in the European medical device market.
Exactech Mar-26 Exactech is progressing through a Chapter 11 bankruptcy restructuring process initiated in response to significant financial and legal pressures from product liability litigation. The court-supervised restructuring aims to address outstanding claims related to device recalls while stabilizing operations, highlighting the material impact of long-term litigation exposure on mid-sized orthopedic implant manufacturers.
Think Surgical Mar-26 Think Surgical continues to expand the compatibility of its ID-HUB digital database and TMINI robotic platform by integrating new implant modules. This strategy focuses on maintaining an "open platform" approach that allows for greater surgeon choice and standardized data-driven planning, further accelerating the adoption of robotic-assisted workflows in orthopedic surgery.
Smith+Nephew Nov-23 Smith+Nephew acquired CartiHeal, developer of the Agili-C cartilage repair implant, for $330 million. This strategic investment strengthens the company's sports medicine business by integrating regenerative technology into its orthopedic portfolio, addressing a critical need for joint preservation solutions and expanding the company’s innovative offerings for surgeons and patients.
DePuy Synthes Oct-23 DePuy Synthes secured U.S. FDA 510(k) clearance for the TriLEAP lower extremity anatomic plating system. The introduction of this modular technology is designed to address the complex functional requirements of foot and ankle surgical procedures, reinforcing the company's competitiveness in specialized podiatric and orthopedic trauma treatment segments.
Enovis Sep-23 Enovis (formerly DJO, LLC) expanded its domestic manufacturing capacity with the opening of a new U.S. facility dedicated to the production of reconstructive knee, hip, and shoulder implants. The investment enhances the company’s supply chain resilience and operational scale, supporting its ability to meet rising clinical demand for joint replacement solutions.
Stryker Sep-23 Stryker launched the PROstep MIS Lapidus system, a novel internal fixation platform for bunion correction. By enabling a minimally invasive surgical approach for hallux valgus deformity and first metatarsal cuneiform joint fusion, the system provides a significant clinical advancement for orthopedic specialists and improves procedural efficiency in foot and ankle care.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Orthopedic Devices Market — Custom Segments

Segment Sub-Segment
No segment data available.

Orthopedic Devices Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the current revenue of the orthopedic devices market?

In 2026 the market for orthopedic devices is valued at USD 67.3 billion.

What are the growth projections for the orthopedic devices industry?

Orthopedic Devices Market size is predicted to expand from USD 64.85 billion in 2025 to USD 99.75 billion by 2035 with growth underpinned by a CAGR above 4.4% between 2026 and 2035.

How is robotic-assisted orthopedic surgery influencing implant selection and hospital purchasing behavior?

Robotic-assisted procedures are increasing demand for implants compatible with precision planning and alignment workflows. Hospitals prioritize systems that integrate with navigation technologies, improving surgical accuracy and supporting differentiated orthopedic service offerings.

How are aging populations and ambulatory surgery center expansion reshaping orthopedic device demand patterns?

Rising degenerative conditions increase implant demand, while the shift toward outpatient care drives preference for devices that reduce procedure time and support faster recovery, aligning procurement with efficiency-focused surgical environments.

Why are Hospitals the leading end-use segment in the orthopedic devices market?

Hospitals represented 62.57% of the market in 2025, driven by their advanced surgical infrastructure, specialized orthopedic teams, and ability to manage complex procedures, trauma care, and rehabilitation services.

Why is Orthobiologics the fastest-growing product segment in the orthopedic devices market?

Orthobiologics is growing rapidly as surgeons increasingly use regenerative solutions to enhance bone healing and tissue repair alongside conventional orthopedic procedures and implant-based treatments.

Why is North America the largest regional market for orthopedic devices?

North America held a 47.70% market share in 2025, driven by mature orthopedic care, strong adoption of advanced implants, high procedure volumes, and broad access to specialized treatment.

What factors are accelerating orthopedic devices market growth in Asia Pacific?

Asia Pacific is expected to expand at a 5.02% CAGR as healthcare access improves, hospital infrastructure grows, and more patients receive orthopedic diagnosis, surgery, and modern device-based treatment.

Which companies are driving growth in the orthopedic devices landscape?

Top companies in the orthopedic devices market include Medtronic plc (Ireland), Stryker Corporation (United States), Zimmer Biomet Holdings, Inc. (United States), DePuy Synthes, Inc. (United States), Smith & Nephew plc (United Kingdom), B. Braun Melsungen AG (Germany), CONMED Corporation (United States), Globus Medical, Inc. (United States), Enovis Corporation (United States), Arthrex, Inc. (United States).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →